Article
A newly constructed STC2/FPR1 dual genes signature works as a prognosis risk indicator with implication in the macrophages dominated and TIM-3 checkpoint related osteosarcoma immune landscape
2024-12-17
Abstract excerpt
<title>Abstract</title> <p>Background Osteosarcoma has been a common bone malignancy occurring in children and adolescents. Attributing to high tumor heterogeneity, none specific breakthrough has been received in targeted gene therapy for osteosarcoma, although it’s still of great potential for immunotherapy in clinical application. In the study, 5 GEO profiles containing transcriptome information of 109 osteosa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 29da3fec-0e8b-53c8-84df-7de19edeef4d
- DOI
- 10.21203/rs.3.rs-5612703/v1
